BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9695411)

  • 21. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
    Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
    Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of N-ras gene mutation after relapse in acute lymphoblastic leukemia.
    Terada N; Miyoshi J; Kawa-Ha K; Sasai H; Orita S; Yumura-Yagi K; Hara J; Fujinami A; Kakunaga T
    Blood; 1990 Jan; 75(2):453-7. PubMed ID: 1967219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oncogenes in human leukemia].
    Takaku F
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):617-23. PubMed ID: 2650633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.
    Case M; Matheson E; Minto L; Hassan R; Harrison CJ; Bown N; Bailey S; Vormoor J; Hall AG; Irving JA
    Cancer Res; 2008 Aug; 68(16):6803-9. PubMed ID: 18701506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of ras gene mutations and methylation state in human leukemias.
    Browett PJ; Norton JD
    Oncogene; 1989 Aug; 4(8):1029-36. PubMed ID: 2668844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
    Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
    J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene.
    Tsuda H; Satarug S; Bhudhisawasdi V; Kihana T; Sugimura T; Hirohashi S
    Mol Carcinog; 1992; 6(4):266-9. PubMed ID: 1336666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
    Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
    Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAS mutation is associated with hyperdiploidy and parental characteristics in pediatric acute lymphoblastic leukemia.
    Wiemels JL; Zhang Y; Chang J; Zheng S; Metayer C; Zhang L; Smith MT; Ma X; Selvin S; Buffler PA; Wiencke JK
    Leukemia; 2005 Mar; 19(3):415-9. PubMed ID: 15674422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RAS mutations in pediatric leukemias with MLL gene rearrangements.
    Mahgoub N; Parker RI; Hosler MR; Close P; Winick NJ; Masterson M; Shannon KM; Felix CA
    Genes Chromosomes Cancer; 1998 Mar; 21(3):270-5. PubMed ID: 9523205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
    Ishida H; Iguchi A; Aoe M; Takahashi T; Tamefusa K; Kanamitsu K; Fujiwara K; Washio K; Matsubara T; Tsukahara H; Sanada M; Shimada A
    Ann Hematol; 2019 Mar; 98(3):657-668. PubMed ID: 30446805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
    Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
    Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations and expression of the ras family genes in leukemias.
    Gougopoulou DM; Kiaris H; Ergazaki M; Anagnostopoulos NI; Grigoraki V; Spandidos DA
    Stem Cells; 1996 Nov; 14(6):725-9. PubMed ID: 8948029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Zhang J; Mullighan CG; Harvey RC; Wu G; Chen X; Edmonson M; Buetow KH; Carroll WL; Chen IM; Devidas M; Gerhard DS; Loh ML; Reaman GH; Relling MV; Camitta BM; Bowman WP; Smith MA; Willman CL; Downing JR; Hunger SP
    Blood; 2011 Sep; 118(11):3080-7. PubMed ID: 21680795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
    Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
    Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan Association of Childhood Leukemia Study.
    Horibe K; Hara J; Yagi K; Tawa A; Komada Y; Oda M; Nishimura S; Ishikawa Y; Kudoh T; Ueda K
    Int J Hematol; 2000 Jul; 72(1):61-8. PubMed ID: 10979211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
    Kubo K; Naoe T; Kiyoi H; Fukutani H; Kato Y; Oguri T; Yamamori S; Akatsuka Y; Kodera Y; Ohno R
    Jpn J Cancer Res; 1993 Apr; 84(4):379-87. PubMed ID: 8514604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
    Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
    Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.